AzTrials
AzTrials

Blood Transfusion ComplicationNCT05922163

Blood Transfusion Education Using Blended Virtual Reality and Simulation for Nursing Undergraduate Students

A study testing Evidence-based VR simulation in people with Blood Transfusion Complication, run by The University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Nurse-administered blood transfusion (BT) is a common form of medical treatment, but nursing students are often excluded from participating in and observing BTs during clinical placements. Read more about this study

Who is it for?
Any age
Conditions the study is for
Blood Transfusion Complication
What is being tested?
Evidence-based VR simulation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
151 participants
Where
1 siteHong Kong
Study dates
1 Mar 2022to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • All undergraduate nursing students enrolled in the 'Nursing of Adults' course in a pre-licensure program at a Hong Kong university.

Who cannot join

  • Students who had vision impairment to watch VR videos;
  • Students who had neck pain/ injury to move their head, or open wound to wear the VR headset;
  • Students who experienced nausea and dizziness when watching VR videos;
  • Students who had epileptic symptoms

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • University of Hong Kong

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Blood Transfusion Education Using Blended Virtual Reality and Simulation for Nursing Undergraduate Students: a Randomized Controlled Trial

Nurse-administered blood transfusion (BT) is a common form of medical treatment, but nursing students are often excluded from participating in and observing BTs during clinical placements. To address clinical placement limitations, nursing educators have increasingly adopted technology-guided simulation pedagogies, including virtual reality (VR) simulation, for nursing students' clinical skills education.

Being tested
Evidence-based VR simulation
Keywords
Blood transfusion, Nursing education, Nursing practice, Simulation, Virtual reality
Medical subject headings
Transfusion Reaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Evidence-based VR simulationDevice

    Evidence-based VR simulation videos on BTs for nursing students were developed, including 1) animated blood formation physiology and side effects of BT and 2) 360° BT nursing practice.

Study groups in NCT05922163
Study groupRoleWhat they receive
Intervention GroupExperimentalReceive the usual blood transfusion education (i.e. Zoom lecture) with the developed VR (Virtual Reality) video education.
Receives: Device: Evidence-based VR simulation
Control GroupNo interventionReceive the usual blood transfusion education (i.e. Zoom lecture) only.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood transfusion knowledge scale (optimised version of the routine blood transfusion knowledge questionnaire [RBTKQ-O])

    A 34-item scale with score ranging from 0 to 34, higher scores indicate higher levels of blood transfusion knowledge.

    Measured: 12-week

Secondary outcomes (2)
  1. Student satisfaction and self-confidence scale [SSSC]

    A 13-item scale with score ranging from 13 to 65, higher scores in both subscales refer to higher satisfaction levels with the intervention and self-confidence in conducting blood transfusion practice, respectively.

    Measured: 12-week

  2. General self-efficacy scale [GSES]

    A 10-item scale with score ranging from 10 to 40, higher scores indicate higher levels of self-efficacy regarding blood transfusion practice.

    Measured: 12-week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2023
  2. Study start1 Mar 2022
  3. Primary completion30 Jun 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
151 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05922163
Sponsor's protocol ID
VR2022
Status last verified
Jun 2023
First submitted
18 Jun 2023
Last updated
28 Jun 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Evidence-based VR simulation in people with Blood Transfusion Complication, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood transfusion knowledge scale (optimised version of the routine blood transfusion knowledge questionnaire [RBTKQ-O]) (time frame: 12-week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in